FTC Approves Final Order Preserving Competition in Generic Drug Market for Treating Dry Mouth and Biliary Cirrhosis
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Impax Laboratories Inc.’s acquisition of CorePharma, LLC would likely be...